EVRAZ (EVR) Stock Rating Upgraded by Goldman Sachs Group

EVRAZ (LON:EVR) was upgraded by investment analysts at Goldman Sachs Group to a “buy” rating in a research report issued on Monday. The brokerage presently has a GBX 430 ($5.94) price objective on the stock, up from their previous price objective of GBX 300 ($4.14). Goldman Sachs Group’s target price indicates a potential upside of 22.06% from the stock’s previous close.

Separately, Jefferies Group reiterated an “underperform” rating and set a GBX 200 ($2.76) price target on shares of EVRAZ in a research report on Thursday, October 19th.

Shares of EVRAZ (LON:EVR) traded up GBX 19.20 ($0.27) on Monday, hitting GBX 352.30 ($4.87). The company had a trading volume of 3,540,241 shares, compared to its average volume of 3,310,000. EVRAZ has a 52-week low of GBX 169.80 ($2.35) and a 52-week high of GBX 401.30 ($5.54). The stock has a market capitalization of $5,050.00 and a PE ratio of -4,403.75.

TRADEMARK VIOLATION NOTICE: This story was published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2018/02/12/evraz-evr-stock-rating-upgraded-by-goldman-sachs-group.html.

EVRAZ Company Profile

EVRAZ plc is a steel, mining and vanadium business with operations in the Russian Federation, Ukraine, the United States, Canada, the Czech Republic, Italy, Kazakhstan and South Africa. The Company’s principal activities include manufacturing steel and steel products; iron ore mining and enrichment; coal mining; manufacturing vanadium products, and trading operations and logistics.

Receive News & Ratings for EVRAZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EVRAZ and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply